{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:24:59Z","timestamp":1793658299693,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T00:00:00Z","timestamp":1378857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12253-013-9692-3","type":"journal-article","created":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T05:51:15Z","timestamp":1378792275000},"page":"277-284","source":"Crossref","is-referenced-by-count":17,"title":["Ephrin Receptor (Eph) -A1, -A2, -A4 and -A7 Expression in Mobile Tongue Squamous Cell Carcinoma: Associations with Clinicopathological Parameters and Patients Survival"],"prefix":"10.1007","volume":"20","author":[{"given":"Stamatios","family":"Theocharis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Giaginis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sastre-Garau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,11]]},"reference":[{"key":"9692_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/path.1937","volume":"208","author":"J Zhang","year":"2006","unstructured":"Zhang J, Hughes SE (2006) Role of the ephrin and Ephrin receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 208:453\u2013461","journal-title":"J Pathol"},{"key":"9692_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","volume":"133","author":"EB Pasquale","year":"2008","unstructured":"Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38\u201352","journal-title":"Cell"},{"key":"9692_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jemt.10177","volume":"59","author":"M Nakamoto","year":"2002","unstructured":"Nakamoto M, Bergemann AD (2002) Diverse role for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc Res Tech 59:58\u201367","journal-title":"Microsc Res Tech"},{"key":"9692_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2004.09.002","volume":"15","author":"H Surawska","year":"2004","unstructured":"Surawska H, Ma PC, Salgia R (2004) The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15:419\u2013433","journal-title":"Cytokine Growth Factor Rev"},{"key":"9692_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1359-6101(01)00031-4","volume":"13","author":"N Cheng","year":"2002","unstructured":"Cheng N, Brantley DM, Chen J (2002) The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13:75\u201385","journal-title":"Cytokine Growth Factor Rev"},{"key":"9692_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:AGEN.0000037340.33788.87","volume":"7","author":"DM Brandley-Sieders","year":"2007","unstructured":"Brandley-Sieders DM, Chen J (2007) Eph receptor tyrosine kinase in angiogenesis: from development to disease. Angiogenesis 7:17\u201328","journal-title":"Angiogenesis"},{"key":"9692_CR7","first-page":"1011","volume":"23","author":"J Casta\u00f1o","year":"2008","unstructured":"Casta\u00f1o J, Davalos V, Schwartz S Jr, Arango D (2008) EPH receptors in cancer. Histol Histopathol 23:1011\u20131023","journal-title":"Histol Histopathol"},{"key":"9692_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568009053765780","volume":"5","author":"RC Ireton","year":"2005","unstructured":"Ireton RC, Chen J (2005) EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. Curr Cancer Drug Targets 5:149\u2013157","journal-title":"Curr Cancer Drug Targets"},{"key":"9692_CR9","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.2174\/1381612043383160","volume":"10","author":"D Brantley-Sieders","year":"2004","unstructured":"Brantley-Sieders D, Schmidt S, Parker M, Chen J (2004) Eph receptor tyrosine kinases in tumor and tumor microenvironment. Curr Pharm Des 10:3431\u20133442","journal-title":"Curr Pharm Des"},{"key":"9692_CR10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.yexcr.2005.10.028","volume":"312","author":"M Heroult","year":"2004","unstructured":"Heroult M, Schaffner F, Augustin HG (2004) Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312:642\u2013650","journal-title":"Exp Cell Res"},{"key":"9692_CR11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S1368-8375(01)00109-9","volume":"38","author":"MT Canto","year":"2002","unstructured":"Canto MT, Devesa SS (2002) Oral cavity and pharynx cancer incidence in the United States, 1975\u20131988. Oral Oncol 38:610\u2013617","journal-title":"Oral Oncol"},{"key":"9692_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"key":"9692_CR13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360:1131\u20131135","journal-title":"Lancet"},{"key":"9692_CR14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20\u201344 years. Cancer 103:1843\u20131849","journal-title":"Cancer"},{"key":"9692_CR15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26:645\u2013662","journal-title":"Cancer Metastasis Rev"},{"key":"9692_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1054\/bjoc.2000.1323","volume":"83","author":"S Kantola","year":"2000","unstructured":"Kantola S, Parikka M, Jokinen K et al (2000) Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 83:614\u2013619","journal-title":"Br J Cancer"},{"key":"9692_CR17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjc.6604633","volume":"99","author":"D Wangsa","year":"2008","unstructured":"Wangsa D, Ryott M, Avall-Lundquist E et al (2008) Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer 99:1121\u20131128","journal-title":"Br J Cancer"},{"key":"9692_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12253-009-9221-6","volume":"16","author":"C Giaginis","year":"2010","unstructured":"Giaginis C, Tsourouflis G, Zizi-Serbetzoglou A, Kouraklis G, Chatzopoulou E, Theocharis S (2010) Clinical significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 receptors in pancreatic ductal adenocarcinoma. Pathol Oncol Res 16:267\u2013276","journal-title":"Pathol Oncol Res"},{"key":"9692_CR19","doi-asserted-by":"crossref","first-page":"BR257","DOI":"10.12659\/MSM.881929","volume":"17","author":"NP Karidis","year":"2011","unstructured":"Karidis NP, Giaginis C, Tsourouflis G, Alexandrou P, Delladetsima I, Theocharis S (2011) Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit 17:BR257\u2013BR265","journal-title":"Med Sci Monit"},{"key":"9692_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","volume":"29","author":"M Brandwein-Gensler","year":"2005","unstructured":"Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005) Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29:167\u2013178","journal-title":"Am J Surg Pathol"},{"key":"9692_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000227604","volume":"54","author":"S Shintani","year":"1997","unstructured":"Shintani S, Matsura H, Hasegawa Y, Nakayama B, Fujimoto Y (1997) The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue. Oncology 54:463\u2013467","journal-title":"Oncology"},{"key":"9692_CR22","volume-title":"World Health Organization classifications tumours. Pathology and genetics of head and neck tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson JW, Reichert P, Sidransky D (2005) World Health Organization classifications tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon"},{"key":"9692_CR23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hed.10094","volume":"24","author":"A Po Wing Yen","year":"2002","unstructured":"Po Wing Yen A, Lam KY, Lam LK et al (2002) Prognostic factors clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score and pathologic features. Head Neck 24:513\u2013520","journal-title":"Head Neck"},{"key":"9692_CR24","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/1097-0142(19950401)75:7<1649::AID-CNCR2820750715>3.0.CO;2-E","volume":"75","author":"J Klijanienko","year":"1995","unstructured":"Klijanienko J, el-Naggar AK, de Braud F (1995) Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75:1649\u20131656","journal-title":"Cancer"},{"key":"9692_CR25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1600-0714.2011.01031.x","volume":"40","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C et al (2011) Histone deacetylase (HDAC)-1 and \u22122 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Oral Med Pathol 40:706\u2013714","journal-title":"J Oral Med Pathol"},{"key":"9692_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2559.2011.03947.x","volume":"59","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C et al (2011) Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. Histopathology 59:514\u2013525","journal-title":"Histopathology"},{"key":"9692_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/modpathol.2008.188","volume":"22","author":"Y Dong","year":"2009","unstructured":"Dong Y, Wang J, Sheng Z et al (2009) Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis. Mod Pathol 22:151\u2013160","journal-title":"Mod Pathol"},{"key":"9692_CR28","first-page":"605","volume":"11","author":"T Saito","year":"2004","unstructured":"Saito T, Masuda N, Miyazaki T et al (2004) Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Oncol Rep 11:605\u2013611","journal-title":"Oncol Rep"},{"key":"9692_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/1078-0432.CCR-05-1505","volume":"12","author":"S Abraham","year":"2006","unstructured":"Abraham S, Knapp DW, Cheng L et al (2006) Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res 12:353\u2013360","journal-title":"Clin Cancer Res"},{"key":"9692_CR30","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/jcp.2006.041194","volume":"60","author":"R Holm","year":"2007","unstructured":"Holm R, Knopp S, Suo Z, Trop\u00e8 C, Nesland JM (2007) Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis. J Clin Pathol 60:1086\u20131091","journal-title":"J Clin Pathol"},{"key":"9692_CR31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/modpathol.3800660","volume":"19","author":"C Hafner","year":"2006","unstructured":"Hafner C, Becker B, Landthaler M, Vogt T (2006) Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 19:1369\u20131377","journal-title":"Mod Pathol"},{"key":"9692_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.22415","volume":"109","author":"YG Lin","year":"2007","unstructured":"Lin YG, Han LY, Kamat AA et al (2007) EphA2 overexpression is associated with angiogenesis in ovarian cancer. Cancer 109:332\u2013340","journal-title":"Cancer"},{"key":"9692_CR33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12253-008-9132-y","volume":"15","author":"W Yuan","year":"2009","unstructured":"Yuan W, Chen Z, Wu S et al (2009) Expression of EphA2 and E-cadherin in Gastric Cancer: correlated with Tumor Progression and Lymphogenous Metastasis. Pathol Oncol Res 15:473\u2013478","journal-title":"Pathol Oncol Res"},{"key":"9692_CR34","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/S0002-9440(10)63584-5","volume":"163","author":"G Zeng","year":"2003","unstructured":"Zeng G, Hu Z, Kinch MS et al (2003) High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol 163:2271\u20132276","journal-title":"Am J Pathol"},{"key":"9692_CR35","first-page":"613","volume":"9","author":"MS Kinch","year":"2003","unstructured":"Kinch MS, Moore MB, Harpole DH (2003) Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 9:613\u2013618","journal-title":"Clin Cancer Res"},{"key":"9692_CR36","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.oraloncology.2008.01.018","volume":"44","author":"Z Shao","year":"2008","unstructured":"Shao Z, Zhang WF, Chen XM, Shang ZJ (2008) Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral Oncol 44:1110\u20131117","journal-title":"Oral Oncol"},{"key":"9692_CR37","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/cncr.24335","volume":"115","author":"AA Kamat","year":"2009","unstructured":"Kamat AA, Coffey D, Merritt WM et al (2009) EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer 115:2684\u20132692","journal-title":"Cancer"},{"key":"9692_CR38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ijc.10860","volume":"103","author":"T Miyazaki","year":"2003","unstructured":"Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H (2003) EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 103:657\u2013663","journal-title":"Int J Cancer"},{"key":"9692_CR39","first-page":"151","volume":"19","author":"LF Wang","year":"2008","unstructured":"Wang LF, Fokas E, Bieker M et al (2008) Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep 19:151\u2013156","journal-title":"Oncol Rep"},{"key":"9692_CR40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/1078-0432.226.11.1","volume":"11","author":"CJ Herrem","year":"2005","unstructured":"Herrem CJ, Tatsumi T, Olson KS et al (2005) Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma. Clin Cancer Res 11:226\u2013231","journal-title":"Clin Cancer Res"},{"key":"9692_CR41","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.3748\/wjg.14.5650","volume":"14","author":"M Oki","year":"2008","unstructured":"Oki M, Yamamoto H, Taniguchi H, Adachi Y, Imai K, Shinomura Y (2008) Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers. World J Gastroenterol 14:5650\u20135656","journal-title":"World J Gastroenterol"},{"key":"9692_CR42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2407-8-79","volume":"8","author":"LF Wang","year":"2008","unstructured":"Wang LF, Fokas E, Juricko J et al (2008) Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer 8:79","journal-title":"BMC Cancer"},{"key":"9692_CR43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 10:165\u2013180","journal-title":"Nat Rev Cancer"},{"key":"9692_CR44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/14728222.2011.538682","volume":"15","author":"M Tandon","year":"2011","unstructured":"Tandon M, Vemula SV, Mittal SK (2011) Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Targets 15:31\u201351","journal-title":"Expert Opin Ther Targets"},{"key":"9692_CR45","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","volume":"65","author":"CN Landen Jr","year":"2005","unstructured":"Landen CN Jr, Chavez-Reyes A, Bucana C et al (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65:6910\u20136918","journal-title":"Cancer Res"},{"key":"9692_CR46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4161\/cbt.8.11.8523","volume":"8","author":"MM Shahzad","year":"2009","unstructured":"Shahzad MM, Lu C, Lee JW et al (2009) Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther 8:1027\u20131034","journal-title":"Cancer Biol Ther"},{"key":"9692_CR47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/0008-5472.CAN-09-1845","volume":"70","author":"G Zhuang","year":"2010","unstructured":"Zhuang G, Brantley-Sieders DM, Vaught D et al (2010) Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. Cancer Res 70:299\u2013308","journal-title":"Cancer Res"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9692-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9692-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T13:02:47Z","timestamp":1688475767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,11]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["9692"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9692-3","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,11]]}}}